IGHE and asthma: Within the context of the Severe Asthma Research Program (SARP) project, it was observed that some severe asthmatic patients who had a more severe reduction of FEF25-75 also displayed more symptoms and a greater need for medication, as well as higher FeNO levels, total serum IgE concentrations, and bronchial hyperresponsiveness [29].